Cargando…

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario

Background and Objective. Bacterial resistance to antibiotics traditionally used to treat uncomplicated urinary tract infections (uUTIs) is rising in Canada. We compared the cost-per-patient in Ontario of including fosfomycin (an antibiotic with a low resistance profile) as an option for first-line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrault, Louise, Dahan, Sybil, Iliza, Ange Christelle, LeLorier, Jacques, Zhanel, George G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337864/ https://www.ncbi.nlm.nih.gov/pubmed/28316632 http://dx.doi.org/10.1155/2017/6362804

Ejemplares similares

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin
por: Mitchell, Dominic, et al.
Publicado: (2016)

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
por: Zhanel, George G., et al.
Publicado: (2020)

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis
por: Zhanel, George G., et al.
Publicado: (2016)

Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial
por: Gágyor, Ildikó, et al.
Publicado: (2015)

A Cost-Effectiveness Analysis of Fosfomycin: A Single-Dose Antibiotic Therapy for Treatment of Uncomplicated Urinary Tract Infection
por: Kassabian, Morgan, et al.
Publicado: (2022)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
por: Shafrir, Asher, et al.
Publicado: (2023)

Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
por: Guertin, Jason R, et al.
Publicado: (2015)

Effective Treatment for Uncomplicated Urinary Tract Infections with Oral Fosfomycin, Single Center Four Year Retrospective Study
por: Fajfr, Miroslav, et al.
Publicado: (2020)

Pharmacologically pertinent period of effect (PPPE)
por: Suissa, Melanie, et al.
Publicado: (2019)

Efficacy of Single Dose of Fosfomycin Versus a Five-Day Course of Ciprofloxacin in Patients With Uncomplicated Urinary Tract Infection
por: Hassan, Muhammad Mujeeb, et al.
Publicado: (2022)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada
por: Zhanel, George G., et al.
Publicado: (2018)

Cost effectiveness of ‘on demand’ HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada
por: Ouellet, Estelle, et al.
Publicado: (2015)

Performance of the high-dimensional propensity score in adjusting for unmeasured confounders
por: Guertin, Jason R, et al.
Publicado: (2016)

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
por: Zhanel, George G., et al.
Publicado: (2018)

Fosfomycin for management of persistent female lower urinary tract infection
por: Joob, Beuy, et al.
Publicado: (2018)

A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation
por: Nakhlé, Gisèle, et al.
Publicado: (2023)

Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
por: Matthews, Philippa C., et al.
Publicado: (2016)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis
por: Milan, Raymond, et al.
Publicado: (2022)

Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists
por: Sanyal, Chiranjeev, et al.
Publicado: (2019)

Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs Fosfomycin
por: Grant, Rebecca, et al.
Publicado: (2023)

A Comparative Study of Urinary Tests and Cultures for the Effectiveness of Fosfomycin in Catheter-Related Urinary Tract Infections
por: Jo, Jung Ki, et al.
Publicado: (2022)

A Case of Intermittent Left Bundle Branch Block
por: Saad, Syed M, et al.
Publicado: (2021)

Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting
por: Derington, Catherine G, et al.
Publicado: (2020)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

Psychosocial burden of recurrent uncomplicated urinary tract infections
por: Naber, Kurt G., et al.
Publicado: (2022)

1526. Oral Fosfomycin Use for Urinary Tract Infections and Its Clinical Impact on Hospital Stay
por: Mai, Christina, et al.
Publicado: (2018)

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
por: Bouiller, Kévin, et al.
Publicado: (2022)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020)

Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care
por: Bosmans, Judith E., et al.
Publicado: (2017)

Cost-effectiveness of antibiotic treatment of uncomplicated urinary tract infection in women: a comparison of four antibiotics
por: Sadler, Susannah, et al.
Publicado: (2017)

P19 Burden of illness and costs among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

Cardiac Manifestations in a Case of Severe Hyperkalemia
por: Saad, Syed M, et al.
Publicado: (2021)

VENTRICULAR ARRHYTHMIA AND SINUS PAUSE IN THE SETTING OF COVID-19
por: Ahmed, Jameel, et al.
Publicado: (2022)

Predictors of Symptom Duration and Bacteriuria in Uncomplicated Urinary Tract Infection
por: Bollestad, Marianne, et al.
Publicado: (2018)

Recurrent uncomplicated urinary tract infections: definitions and risk factors
por: Cai, Tommaso
Publicado: (2021)

Treatment of uncomplicated symptomatic urinary tract infections: Resistance patterns and misuse of antibiotics
por: George, Carolin Elizabeth, et al.
Publicado: (2015)

Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa
por: Yang, Xuan, et al.
Publicado: (2018)

Sex differences in factors associated with switch between systemic agents among individuals with psoriasis: A retrospective cohort study in Quebec, Canada
por: Milan, Raymond, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4dcf0cr1efr94u1a4cfl8ch6td